ANTXR2 and cancer: A multivariate Cox’s regression analysis adjusted to tumor localization, tumor stage, tumor entity, and resection mode revealed a 2.12-fold increased risk of cancer-related death for patients with a low CMG2 mRNA expression (p = 0.019; see Figure 3b).